Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
764
-
Total 13F shares, excl. options
-
212M
-
Shares change
-
-1.64M
-
Total reported value, excl. options
-
$64.7B
-
Value change
-
-$452M
-
Put/Call ratio
-
1.5
-
Number of buys
-
361
-
Number of sells
-
-333
-
Price
-
$305.87
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q1 2014
862 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q1 2014.
BIOGEN INC. - Common Stock (BIIB) has 764 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 212M shares
.
Largest 10 shareholders include FMR LLC (21.9M shares), PRIMECAP MANAGEMENT CO/CA/ (17.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.2M shares), VANGUARD GROUP INC (11.9M shares), State Street Corp (9.55M shares), Capital Research Global Investors (8.54M shares), Clearbridge Investments, LLC (7.7M shares), JENNISON ASSOCIATES LLC (6.34M shares), JPMORGAN CHASE & CO (6.18M shares), and BlackRock Institutional Trust Company, N.A. (6.15M shares).
This table shows the top 764 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.